Stephan M Huber Selected Research

Waste Products (Waste Product)

12/2012	Decreased redox-sensitive erythrocyte cation channel activity in aquaporin 9-deficient mice.
11/2008	Organic osmolyte channels in malaria-infected erythrocytes.
8/2005	Permselectivity and pH-dependence of Plasmodium falciparum-induced anion currents in human erythrocytes.
1/2002	Plasmodium falciparum activates endogenous Cl(-) channels of human erythrocytes by membrane oxidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan M Huber Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2010
24	Malaria 12/2012 - 01/2002
19	Infections 12/2012 - 01/2004
12	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2011
8	Hemolysis 11/2010 - 01/2002
8	Parasitemia 10/2010 - 11/2007
7	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2013
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2009 - 01/2002
5	Iron Deficiencies 01/2009 - 02/2006
4	Hypoxia (Hypoxemia) 01/2022 - 08/2015
4	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2016
4	Anemia 08/2010 - 11/2003
4	Hepatolenticular Degeneration (Wilson's Disease) 01/2009 - 02/2007
4	Glucosephosphate Dehydrogenase Deficiency 07/2006 - 01/2002
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
3	Leukemia 01/2020 - 01/2010
3	Glioma (Gliomas) 01/2019 - 09/2015
3	Hemolytic Anemia 11/2010 - 05/2007
3	Shock 08/2010 - 11/2003
3	Sepsis (Septicemia) 01/2009 - 01/2008
3	Thalassemia 07/2006 - 01/2002
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 08/2013
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
2	Carcinogenesis 01/2019 - 12/2017
2	beta-Thalassemia (Cooley's Anemia) 01/2009 - 10/2008
1	Disease Progression 01/2022
1	Alcoholism (Alcohol Abuse) 10/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

16	CationsIBA 01/2016 - 03/2002
9	Proteins (Proteins, Gene)FDA Link 11/2017 - 01/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2008
7	Messenger RNA (mRNA)IBA 01/2022 - 08/2014
6	Glucose (Dextrose)FDA LinkGeneric 05/2013 - 01/2002
6	PhosphatidylserinesIBA 10/2010 - 02/2007
6	AnionsIBA 03/2009 - 04/2004
6	AnnexinsIBA 11/2008 - 01/2002
5	Ion Channels (Ion Channel)IBA 01/2019 - 08/2013
5	RNA (Ribonucleic Acid)IBA 10/2010 - 01/2008
4	Fura-2 (Fura 2)IBA 01/2020 - 08/2013
4	CytokinesIBA 04/2018 - 01/2017
4	Waste Products (Waste Product)IBA 12/2012 - 01/2002
4	Drinking WaterIBA 01/2008 - 11/2007
3	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022 - 10/2011
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 04/2004
3	Pharmaceutical PreparationsIBA 10/2021 - 01/2017
3	Potassium Channels (Potassium Channel)IBA 01/2021 - 08/2013
3	Adenosine Triphosphate (ATP)IBA 05/2013 - 01/2006
3	Annexin A5IBA 10/2010 - 02/2006
3	Sucrose (Saccharose)IBA 08/2010 - 01/2002
3	Phosphates (Orthophosphate)IBA 01/2009 - 01/2008
3	Erythropoietin FDA Link 05/2008 - 11/2003
3	ethylisopropylamiloride (EIPA)IBA 01/2008 - 01/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2017
2	IonsIBA 10/2021 - 12/2012
2	viscum album peptide (Iscador)IBA 01/2019 - 01/2018
2	Viscum ribosome inactivating proteinIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 01/2017
2	paxillineIBA 03/2016 - 10/2011
2	N-(3-pyridyl)-3-phenylsuccinimideIBA 12/2012 - 04/2004
2	Purinergic Receptors (Receptors, Purine)IBA 08/2012 - 01/2006
2	Colloids (Colloid)IBA 11/2010 - 11/2008
2	Annexin A7 (Synexin)IBA 08/2010 - 01/2009
2	Chlorpromazine (Thorazine)FDA Link 01/2009 - 01/2008
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2009 - 10/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2009 - 11/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2009
2	ElectrolytesIBA 11/2008 - 06/2008
2	AcidsIBA 01/2008 - 02/2007
2	Reducing AgentsIBA 01/2008 - 01/2002
2	Amiloride (Midamor)FDA LinkGeneric 01/2008 - 03/2002
2	CeramidesIBA 01/2008 - 02/2007
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2008 - 02/2007
2	SolutionsIBA 01/2008 - 04/2004
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	NestinIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Aldehyde DehydrogenaseIBA 10/2021
1	Disulfiram (Antabuse)FDA Link 10/2021
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Methadone (Dolophine)FDA LinkGeneric 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	Docetaxel (Taxotere)FDA Link 09/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019
1	Fluorouracil (Carac)FDA LinkGeneric 09/2019
1	benidipineIBA 01/2019
1	OvalbuminIBA 04/2018

Therapy/Procedure

26	Therapeutics 01/2022 - 11/2003
14	Radiotherapy 01/2020 - 01/2010
3	Immunotherapy 04/2018 - 08/2014
2	Drug Therapy (Chemotherapy) 09/2019 - 01/2019
2	Transplantation 09/2019 - 01/2017
2	Intraperitoneal Injections 03/2017 - 10/2010
2	Intravenous Injections 03/2017 - 11/2010
1	Isogeneic Transplantation 01/2022
1	Aftercare (After-Treatment) 09/2019
1	Electrodes (Electrode) 01/2019